ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE
Clinical Pharmacology Subcommittee
CDER Advisory Committee Conference Room
DRAFT AGENDA
Day 1 -
Conflict of
Interest Kathleen
Reedy, Exec.Sec.
exposure-response
for determining dose
adjustment
for special populations Peter
Lee, Ph.D.
(
for defined
therapeutic targets Mats
Karlsson, Ph.D.
study design
template and analyses of the FDA
pediatric database Lawrence Lesko, Ph.D.
(